Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2010-9-6
pubmed:abstractText
Nasopharyngeal carcinoma (NPC) is usually diagnosed at advanced clinical stages, resulting in poor outcomes. To discover serum biomarkers for improved NPC diagnosis and/or management, we simultaneously analyzed the NPC cell secretome and tissue transcriptome to identify candidate genes/proteins that are highly upregulated in NPC tissues and also secreted/released from NPC cells. Among the 30 candidates identified, 11 proteins were chosen for further validation using the serum samples from NPC patients and healthy controls, including cystatin A, cathepsin B, manganese superoxide dismutase and matrix metalloproteinase 2. The results showed that serum levels of all the four proteins were indeed higher in NPC patients versus healthy controls and that the use of a three-marker panel (cystatin A, manganese superoxide dismutase and matrix metalloproteinase 2) can contribute to a better NPC detection than each marker alone. In addition, a higher pretreated serum level of cystatin A was found to be associated with a higher nodal stage and poorer prognosis of NPC patients and cystatin A could modulate the migration and invasion of NPC cells in vitro. Altogether, our results indicate that analysis of both the cancer cell secretome and tissue transcriptome is a feasible strategy for efficient identification of novel NPC serum marker panel.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1615-9861
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2644-60
pubmed:meshHeading
pubmed-meshheading:20461718-Adolescent, pubmed-meshheading:20461718-Adult, pubmed-meshheading:20461718-Aged, pubmed-meshheading:20461718-Aged, 80 and over, pubmed-meshheading:20461718-Cell Line, Tumor, pubmed-meshheading:20461718-Cell Movement, pubmed-meshheading:20461718-Chromatography, Liquid, pubmed-meshheading:20461718-Cystatin A, pubmed-meshheading:20461718-Female, pubmed-meshheading:20461718-Gene Expression Profiling, pubmed-meshheading:20461718-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20461718-Humans, pubmed-meshheading:20461718-Male, pubmed-meshheading:20461718-Mass Spectrometry, pubmed-meshheading:20461718-Middle Aged, pubmed-meshheading:20461718-Nasopharyngeal Neoplasms, pubmed-meshheading:20461718-Neoplasm Invasiveness, pubmed-meshheading:20461718-Neoplasm Metastasis, pubmed-meshheading:20461718-Neoplasm Proteins, pubmed-meshheading:20461718-Neoplasm Staging, pubmed-meshheading:20461718-Prognosis, pubmed-meshheading:20461718-Reproducibility of Results, pubmed-meshheading:20461718-Survival Analysis, pubmed-meshheading:20461718-Tumor Markers, Biological, pubmed-meshheading:20461718-Young Adult
pubmed:year
2010
pubmed:articleTitle
Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis.
pubmed:affiliation
Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't